Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Sequenom - All Systems Go on Down Syndrome Test
By:
TraderMark
Tuesday, September 23, 2008 6:31 PM
Symbols:
CVS
,
SNP
,
SQNM
Email Article
Bookmark:
Font Size
Print Article
(NASDAQ:
SQNM
-
News
), a leading provider of genetic-analysis and molecular diagnostic solutions, announced additional, positive results from screening studies using the Company
’
s noninvasive circulating cell-free fetal (
ccff
) nucleic acid
SEQureDx
™
Technology, which enables the detection of fetal
aneuploidy
, including Down syndrome from maternal blood, at its Analyst Briefing in New York City.
Among the data presented,
Sequenom
’
s test demonstrated complete concordance with clinical results (no false positives and no false negatives) in both first and second trimester samples (over 200 samples announced today and in excess of 400 prospective samples to-date)
"These data expand upon the data we announced in June and underscore the potential for our
SEQureDx
Technology to transform current clinical practice for prenatal diagnostics as a primary screening tool for
Trisomy
21. Furthermore,
these results support the potential for our test to be used in the first trimester,
" said Harry
Stylli
, Ph.D.,
Sequenom's
President and Chief Executive Officer.
Next Page >>
<< Previous Page
1
2
3
4
Bookmark:
Email Article
Print Article
Related Stories
Research Related Stocks:
CVS
,
SNP
,
SQNM
,
More Articles on:
Medical
ProActive HavRx Stock Indexes: Highlights And Opportunities
M&M Finance: Buy
Options Intellignece Report : Options Activity for PG, CTXS, LINTA, HIG, CVS, UUP, VIX, AONE, SWKS, CLX, BCSI & NVDA
PicksThatMove.com Announces Investment Opinion on Gold Wheaton Corporation, UAL Corporation, Comcast Corporation, CVS Caremark Corporation, and Manulife Financial Corporation
Biostar Raises $3.6 Million
Rate this Commentary
Comments
(0)
No Comments
Post Comment
Name:
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
Advertisement
Related Press Releases
CVS Caremark Corporation Announces New Authorization of Repurchase Program for up to $2 Billion of Common Stock
RidgewaterEquity.com Free Fundamental Sector & Market Research on HOC, MA, CVS, LOW, VTG and HLS
Halter USX China Index Up 10.59% for Third Quarter 2009
Fitch Rates CVS' $1.5B Sr. Unsecured Notes 'BBB+'; Outlook Stable
Recon Technology Secures $971,000 in New Equipment Orders for Chinese Oil and Gas Fields
Popular Articles
Apple Inc (AAPL): Weaker Dollar Will Benefit Revenue Growth And Margins
By:
Financial Alchemist
GE's $19 Billion (And Increasing) Toxic Asset Sink Hole
By:
Tyler Durden
The Scariest Thing On Wall Street - FNM
By:
The Growth Stock Wire
Hot Stocks: Google’s Drive For Dominance Extends Into The Burgeoning Smartphone Market
By:
Money Morning
Natural Gas Companies
By:
Keith Kohl
Advertisement
Special Offers
Recent Articles by TraderMark
Wells Fargo (WFC) Kicks The Can By Transofrming Option ARM Mortgages Into Interest Only
Official Unemployment Rate Hits 10.2%; Reality Is Far Higher
Blue Coat Systems (BCSI) - More Global Labor Arbitrage
Yet Another "V" Shaped Bounce- Old Patterns Seem Useless
Still Many Broken Charts Despite The Index Rallies; Russell 2000 Under Performing
Market Jumps Back Over 50 Day Moving Average As Investors Predict More Easy Money
More Articles by:
TraderMark
More Articles on:
Medical
Research Related Stocks:
CVS
,
SNP
,
SQNM
,
Subscribe to
Email Alerts
or
RSS feeds
for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia